Stocks · Health care · Biological Products, (No Diagnostic Substances)

Taysha Gene Therapies, Inc.

TSHA Clue Score55

United States Fiscal year ends December CIK 0001806310 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$27.01M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$10.78M

$1.32M on a plan · $4.18M straight out of an exercise

Sold at will

$5.28M

36 of 43 sales

Net

+$16.23M

+$21.73M against sales at will